Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

November 30, 2015 4:24 PM ET

Professional Services

Company Overview of H. Lee Moffitt Cancer Center & Research Institute

Company Overview

H. Lee Moffitt Cancer Center & Research Institute is a not for-profit institution that focuses on prevention and cure of cancer. The institution offers private patient rooms, blood and marrow transplant programs, outpatient treatment programs, patient care, research, and education services. Additionally, it publishes Today's Tomorrows, a community newsletter about cancer care, research, and education. H. Lee Moffitt was founded in 1986 and is based in Tampa, Florida.

10441 University Center Drive

Tampa, FL 33612

United States

Founded in 1986



Key Executives for H. Lee Moffitt Cancer Center & Research Institute

Chief Executive Officer and Center Director
Age: 65
Executive Vice President Applied Science
Vice President of Public Relations and Marketing
Compensation as of Fiscal Year 2015.

H. Lee Moffitt Cancer Center & Research Institute Key Developments

Moffitt Cancer Center and Ignyta, Inc. Enter into Cancer Research Collaboration for RXDX-106

Moffitt Cancer Center and Ignyta, Inc. announced that they have entered into research collaboration relating to RXDX-106, Ignyta's small molecule, pseudo irreversible inhibitor of TYRO3, AXL, Mer (TAM) and cMET that is in late stage preclinical development. The collaboration, which will be conducted in the labs of Eric B. Haura, M.D., director of the Lung Cancer Center of Excellence and leader of the Chemical Biology and Molecular Medicine Program at Moffitt, will explore and develop novel protein based diagnostic assays that can assess RXDX-106 signaling activity in relevant solid tumors and associated tumor microenvironments.

H. Lee Moffitt Cancer Center & Research Institute Presents at 2015 BioFlorida Annual Conference, Oct-12-2015 11:40 AM

H. Lee Moffitt Cancer Center & Research Institute Presents at 2015 BioFlorida Annual Conference, Oct-12-2015 11:40 AM. Venue: Omni Orlando Resort at ChampionsGate, 1500 Masters Blvd, ChampionsGate, FL 33896, United States. Speakers: James J. Mule, Executive Vice President Applied Science.

Bristol-Myers Squibb Co. Partners with Moffitt Cancer Center to Advance Immuno-Oncology Research

Bristol-Myers Squibb Co. partnered with Moffitt Cancer Center to advance immuno-oncology research as part of Bristol-Myers' Immuno-Oncology Rare Population Malignancy (I-O RPM) program. Bristol-Myers and Moffitt will conduct various early phase clinical studies. The partnership will foster new Moffitt investigator-initiated studies for rare tumors and gives the faculty opportunity to educate research students about innovative clinical trials.

Similar Private Companies By Industry

Company Name Region
LeanLeasing United States
Covance Market Access Services Inc. United States
Alliance Benefit Group North Central States, Inc. United States
Private Club Associates Inc. United States
Innovation HR Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact H. Lee Moffitt Cancer Center & Research Institute, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at